Source: Virtual Congress 2020 – Asthma pharmacology: clinical trials and mechanistic insights
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
C. Domingo Ribas (Sabadell (Barcelona), Spain), A. Sogo Sagardia (Sabadell (Barcelona), Spain), D. Monserrate Mitchell (Sabadell (Barcelona), Spain), A. Sicras Mainar (Barcelona, Spain), A. Sicras Navarro (Barcelona, Spain), C. Engroba Teijeiro (Barcelona, Spain). Late Breaking Abstract - Target populations for type 2 asthma biologics in a real-life population in Spain (BRAVO 2). 3691

Member's Comments

No comment yet.

Related content which might interest you: Late Breaking Abstract - Prevalence, characterization and costs of severe asthma in Spain (BRAVO 1) Source: Virtual Congress 2020 – Diagnosis and management of asthma Year: 2020 Late Breaking Abstract - A New study of the Prevalence of COPD in Spain: EPISCAN II Source: International Congress 2019 – COPD: epidemiology and spirometry Year: 2019 Late Breaking Abstract - Comparison of clinical characteristics between severe adult asthmatics in Brazil(ProAR) and Europe(U-BIOPRED). Source: International Congress 2017 – Late-breaking findings in asthma and COPD Year: 2017 Late Breaking Abstract - The association of osteoporosis with mortality and symptom burden in a COPD cohort. The HUNT Study, Norway. Source: International Congress 2018 – COPD exacerbations and bronchiectasis Year: 2018 Late Breaking Abstract - Compare outcomes between COPD patients treated with Tiotropium/Olodaterol (TIO/OLO) and other fixed-dose LAMA/LABAs Source: Virtual Congress 2020 – COPD and the impact of comorbidities Year: 2020 Late Breaking Abstract - Oral corticosteroids exposure in a Swedish nationwide asthma population during 2006-2016 Source: International Congress 2018 – Does asthma phenotyping improve treatment? Year: 2018 Late Breaking Abstract - European prevalence of OSA in adults: Estimation using currently available data Source: International Congress 2018 – Epidemiology, phenotypes and cardiometabolic comorbidities of obstructive sleep apnoea Year: 2018 Late Breaking Abstract - International, prospective real-world study of mepolizumab in patients with severe asthma at one year: REALITI-A Source: Virtual Congress 2021 – Advances in asthma treatment Year: 2021 Late Breaking Abstract - Analysing the COPD care pathway in Japan, Canada, England and Germany: pilot study results Source: Virtual Congress 2021 – Prediction of exacerbations in patients with COPD Year: 2021 Late Breaking Abstract: Novel detection of exacerbations of COPD with patient reported outcome (EXACT-PRO) and Blackberry (BB) Source: Annual Congress 2010 - Asthma and COPD: understanding through monitoring Year: 2010 Late Breaking Abstract - Real world patient-reported outcomes in asthma across six European countries: the NEWTON study Source: Virtual Congress 2021 – Airway pharmacology: translational and basic science Year: 2021 Late Breaking Abstract - Comparing respiratory versus cardiovascular event rates, 1987-2016: NHLBI Pooled Cohorts Study Source: International Congress 2017 – COPD: risk factors and prognosis Year: 2017 Late Breaking Abstract - Comparative analysis of effectiveness of Asthma Control Test-guided treatment versus usual care in patients with asthma from China Source: Virtual Congress 2020 – Prediction of outcomes in obstructive diseases Year: 2020 Late Breaking Abstract - Efficacy and safety of tezepelumab in adults with severe asthma: A randomized phase 2 study Source: International Congress 2017 – Late-breaking studies in asthma and COPD Year: 2017 Late Breaking Abstract - Asthma prevalence and management in adults in France in 2018: ASTHMAPOP survey Source: International Congress 2018 – Asthma in children and adults: long-term aspects Year: 2018 Late Breaking Abstract - Compare outcomes between COPD patients treated with tiotropium/olodaterol (TIO/OLO) and umeclidium/vilanterol (UMEC/VI) Source: Virtual Congress 2020 – Burden and predictive factors for chronic lung diseases and comorbidity Year: 2020 Late Breaking Abstract - Longitudinal analysis of variation in clinical features from the U-BIOPRED severe asthma cohort Source: International Congress 2018 – Notable Studies in Asthma Year: 2018 Late Breaking Abstract - The DIAMORFOSIS (DIAgnosis and Management Of lung canceR and FibrOSIS) survey. Source: International Congress 2019 – Idiopathic pulmonary fibrosis and surroundings Year: 2019 Late Breaking Abstract - Characteristics of T2-biomarker low severe asthma patients in the UK Severe Asthma Registry (UKSAR) Source: International Congress 2019 – Asthma epidemiology in the 21st century Year: 2019 Late Breaking Abstract - Identifying preventable early risk factors for asthma in Indigenous children: a population cohort study in Western Australia. Source: Virtual Congress 2020 – Diagnosis and management of asthma Year: 2020